Guidance on the risk assessment of substances present in food intended for infants below 16 weeks of age

被引:127
作者
Hardy, Anthony
Benford, Diane
Halldorsson, Thorhallur
Jeger, Michael John
Knutsen, Helle Katrine
More, Simon
Naegeli, Hanspeter
Noteborn, Hubert
Ockleford, Colin
Ricci, Antonia
Rychen, Guido
Schlatter, Josef R.
Silano, Vittorio
Solecki, Roland
Turck, Dominique
Bresson, Jean-Louis
Dusemund, Birgit
Gundert-Remy, Ursula
Kersting, Mathilde
Lambre, Claude
Penninks, Andre
Tritscher, Angelika
Waalkens-Berendsen, Ine
Woutersen, Ruud
Arcella, Davide
Marques, Daniele Court
Dorne, Jean-Lou
Kass, George E. N.
Mortensen, Alicja
机构
关键词
infants; neonates; ADI; health-based guidance values; development; BLOOD-BRAIN-BARRIER; DRUG-METABOLISM ENZYMES; IMMUNE-SYSTEM; HUMAN-MILK; PHARMACOKINETIC DIFFERENCES; INTESTINAL PERMEABILITY; PRETERM INFANTS; GUT MICROBIOTA; FLUID BARRIER; DEVELOPMENTAL IMMUNOTOXICITY;
D O I
10.2903/j.efsa.2017.4849
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Following a request from the European Commission to EFSA, the EFSA Scientific Committee (SC) prepared a guidance for the risk assessment of substances present in food intended for infants below 16 weeks of age. In its approach to develop this guidance, the EFSA SC took into account, among others, (i) an exposure assessment based on infant formula as the only source of nutrition; (ii) knowledge of organ development in human infants, including the development of the gut, metabolic and excretory capacities, the brain and brain barriers, the immune system, the endocrine and reproductive systems; (iii) the overall toxicological profile of the substance identified through the standard toxicological tests, including critical effects; (iv) the relevance for the human infant of the neonatal experimental animal models used. The EFSA SC notes that during the period from birth up to 16 weeks, infants are expected to be exclusively fed on breast milk and/or infant formula. The EFSA SC views this period as the time where health-based guidance values for the general population do not apply without further considerations. High infant formula consumption per body weight is derived from 95th percentile consumption. The first weeks of life is the time of the highest relative consumption on a body weight basis. Therefore, when performing an exposure assessment, the EFSA SC proposes to use the high consumption value of 260 mL/kg bw per day. A decision tree approach is proposed that enables a risk assessment of substances present in food intended for infants below 16 weeks of age. The additional information needed when testing substances present in food for infants below 16 weeks of age and the approach to be taken for the risk assessment are on a case-by-case basis, depending on whether the substance is added intentionally to food and is systemically available. (C) 2017 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
引用
收藏
页数:58
相关论文
共 275 条
[81]   Phase 0 and phase III transport in various organs: Combined concept of phases in xenobiotic transport and metabolism [J].
Doering, Barbara ;
Petzinger, Ernst .
DRUG METABOLISM REVIEWS, 2014, 46 (03) :261-282
[82]   Host-Microbe Interactions in the Neonatal Intestine: Role of Human Milk Oligosaccharides [J].
Donovan, Sharon M. ;
Wang, Mei ;
Li, Min ;
Friedberg, Iddo ;
Schwartz, Scott L. ;
Chapkin, Robert S. .
ADVANCES IN NUTRITION, 2012, 3 (03) :450S-455S
[83]   Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review [J].
Dorne, JLCM ;
Walton, K ;
Renwick, AG .
FOOD AND CHEMICAL TOXICOLOGY, 2005, 43 (02) :203-216
[84]   Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy [J].
Du Toit, George ;
Roberts, Graham ;
Sayre, Peter H. ;
Bahnson, Henry T. ;
Radulovic, Suzana ;
Santos, Alexandra F. ;
Brough, Helen A. ;
Phippard, Deborah ;
Basting, Monica ;
Feeney, Mary ;
Turcanu, Victor ;
Sever, Michelle L. ;
Lorenzo, Margarita Gomez ;
Plaut, Marshall ;
Lack, Gideon .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (09) :803-813
[85]   Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver [J].
Duanmu, ZB ;
Weckle, A ;
Koukouritaki, SB ;
Hines, RN ;
Falany, JL ;
Falany, CN ;
Kocarek, TA ;
Runge-Morris, M .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (03) :1310-1317
[86]   Guidelines for Feeding Very Low Birth Weight Infants [J].
Dutta, Sourabh ;
Singh, Balpreet ;
Chessell, Lorraine ;
Wilson, Jennifer ;
Janes, Marianne ;
McDonald, Kimberley ;
Shahid, Shaneela ;
Gardner, Victoria A. ;
Hjartarson, Aune ;
Purcha, Margaret ;
Watson, Jennifer ;
de Boer, Chris ;
Gaal, Barbara ;
Fusch, Christoph .
NUTRIENTS, 2015, 7 (01) :423-442
[87]   Development and evaluation of a generic physiologically based pharmacokinetic model for children [J].
Edginton, Andrea N. ;
Schmitt, Walter ;
Willmann, Stefan .
CLINICAL PHARMACOKINETICS, 2006, 45 (10) :1013-1034
[88]   Guidance on the review, revision and development of EFSA's cross-cutting guidance documents [J].
EFSA Scientific Committee .
EFSA JOURNAL, 2015, 13 (04)
[89]   AGE DIFFERENCES IN DRUG BINDING BY PLASMA PROTEINS - STUDIES ON HUMAN FOETUSES, NEONATES AND ADULTS [J].
EHRNEBO, M ;
AGURELL, S ;
JALLING, B ;
BOREUS, LO .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1971, 3 (04) :189-&
[90]   Barriers in the developing brain and Neurotoxicology [J].
Ek, C. Joakim ;
Dziegielewska, Katarzyna M. ;
Habgood, Mark D. ;
Saunders, Norman R. .
NEUROTOXICOLOGY, 2012, 33 (03) :586-604